Prospera Financial Services
PBE icon

Prospera Financial Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Prospera Financial Services’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$870K Buy
+8,490
New +$797K 0.01% 882

Other funds holding PBE

LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Gerber Kawasaki Wealth & Investment Management
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.93B AUM 18.7% 1-Year Est. Return
YHB Investment Advisors
YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return
Institute for Wealth Management
Institute for Wealth Management Denver, Colorado $1.13B AUM 31.46% 1-Year Est. Return
Penobscot Investment Management
Penobscot Investment Management Boston, Massachusetts $1.44B AUM 23.59% 1-Year Est. Return
Massachusetts Wealth Management
Massachusetts Wealth Management North Andover, Massachusetts $248M AUM 37.44% 1-Year Est. Return
Nilsine Partners
Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Outlook Wealth Advisors
Outlook Wealth Advisors Shenandoah, Texas $470M AUM 20.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Prospera Financial Services's PBE Position: Q3 2026 in Review

Prospera Financial Services opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 8,490 shares worth $870K. The stake represents 0.01% of the portfolio and ranks #882 among its holdings.

58 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

  • Prospera Financial Services held 8,490 shares of Invesco Biotechnology & Genome ETF worth $870K as of Q3 2026.
  • Invesco Biotechnology & Genome ETF was a new Prospera Financial Services position in Q3 2026.
  • Invesco Biotechnology & Genome ETF made up 0.01% of Prospera Financial Services's portfolio in Q3 2026, its #882 holding.
  • 58 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.